Pharmaceuticals

10 CISOs in Pharmaceuticals

These ten executives hold or have held the chief information security officer title at pharmaceutical companies. A reader can learn how security leaders in pharma set security strategy, protect research and manufacturing environments, and report on cyber risk to leadership.

10 professionals10 companiesData retrieved September 28, 2026

Professionals to explore

01—10
  1. Andrea Abell

    LinkedIn

    Experience: Chief Information Security Officer · Eli Lilly and Company

    Chief Information Security Officer at Eli Lilly and Company since May 2023, a company the profile describes as a pharmaceutical manufacturer. She was Chief Information Security Officer at NBCUniversal (2017–2023), and at Lockheed Martin she was Information Assurance Engineer Sr Staff (2009–2017) and Project Management & Planning Operations Senior Staff (2007–2008).

  2. Ashish Faujdar

    LinkedIn

    Experience: Global - Chief Information Security Officer · Lupin

    Global - Chief Information Security Officer at Lupin since April 2026; the profile describes Lupin as a global pharmaceutical company from India. He was Group Head - Cyber Security Data Protection at Mahindra Group (2024–2026), Group Chief Information Security Officer & Data Protection Officer at Mahindra Finance (2023–2024) and Head - Cyber Security & Systems Risks at Yes Bank (2011–2021).

  3. Enrico Riccardi

    LinkedIn

    Experience: Group Chief Information Security Officer · Chiesi Group

    Group Chief Information Security Officer at Chiesi Group since November 2011, a role his headline places at Chiesi Farmaceutici; the profile says it covers defining an information security strategy aligned with business objectives. He was previously IT Project Manager at Chiesi Group (2003–2011) and Data Base Administrator at DS Data Systems (1999–2003).

  4. Franck Braunstedter

    LinkedIn

    Experience: Chief Information Security Officer - CISO · Bachem

    Chief Information Security Officer - CISO at Bachem since May 2025; the profile describes Bachem as a pharmaceutical manufacturer specializing in the development and manufacture of peptides and oligonucleotides. At NTT DATA, Inc. he was Senior Director, Security Consulting Europe (2022–2025) and Senior Manager, Cyber Defense & Cloud Security DACH (2017–2020).

  5. Michael Elmore

    LinkedIn

    Experience: SVP & Chief Information Security Officer, GSK · GSK

    SVP & Chief Information Security Officer, GSK at GSK since May 2020. He was also VP, CISO GSK Consumer (now Haleon) at GSK (2019–2021); his profile says that as CISO for Haleon, GSK's consumer healthcare business that was divested in 2022, he was responsible for setting up its cyber security.

  6. Michael Volander

    LinkedIn

    Experience: Group Chief Information Security Officer · MSD

    Group Chief Information Security Officer at MSD since October 2015, after serving as Head Of Information Security at MSD (2014–2015). He was Head Of Information Security at GSK (2009–2014), and at Bank of America he was Chief Information Security Officer (2007–2009) and Security Officer (2004–2007).

  7. Olivier Verack

    LinkedIn

    Experience: Chief Information Security Officer · UCB

    Chief Information Security Officer at UCB since July 2026, alongside the role of Head of enterprise security architecture at UCB held since June 2025. He was Industrial cybersecurity architect at UCB (2023–2025). The profile describes UCB as a biopharmaceutical company focused on neurological and autoimmune conditions.

  8. Pete Naumovski

    LinkedIn

    Experience: Global Chief Information Security Officer (CISO) & VP of IT Risk Management · AbbVie

    Global Chief Information Security Officer (CISO) & VP of IT Risk Management at AbbVie since June 2020, and a Member of the Board of Directors of Health-ISAC since October 2018. He was VP, CISO at Blue Cross Blue Shield Association (2015–2020), where he also served as Interim Chief Information Officer (2019), and Interim CISO (Independent Consultant) at SUPERVALU (2014–2015).

  9. Phil Procker

    LinkedIn

    Experience: Vice President & Chief Information Security Officer (CISO) · Simtra BioPharma Solutions

    Vice President & Chief Information Security Officer (CISO) at Simtra BioPharma Solutions since January 2024. He held the same title at Endo (2012–2023), and was Director, Global IT Security at Barr Laboratories (2006–2009) and Vice President, Information Technology at RHI Entertainment (2009–2012).

  10. Ulla Palmila

    LinkedIn

    Experience: Chief Information Security Officer · Orion Pharma

    Chief Information Security Officer at Orion Pharma since June 2025. At Orion Pharma she was also Information Security Manager (2012–2019) and Infrastructure Owner (2010–2012), and she was Cyber Security Manager at Neste (2019–2025). The profile describes Orion as a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary pharmaceuticals.

Choose the right perspective

Match the company's scale and structure to yours, since a group CISO at a large global drugmaker and a CISO at a mid-sized manufacturer face different budgets, regulators and threats. Consider the path each person took to the role, such as security architecture, IT risk or security consulting, and pick the one whose background fits your problem.

Questions to take into the conversation

  1. 01How do you secure manufacturing and laboratory systems that were never designed to be connected to corporate networks?
  2. 02How do you protect research data and intellectual property when working with CROs, CDMOs and other partners?
  3. 03How do you structure security governance and board reporting in a regulated GxP environment?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Request a correction or removal

Other perspectives in Pharmaceuticals